Endo Announces Launch of OTCQX Trading

MALVERN, Pennsylvania., June 282024 /CNW/ — Endo, Inc. (OTCQX: NDOI) (“Endo” or the “Company”) announced today that the Company has commenced trading on the OTCQX.^® Better Market (“OTCQX”) under the ticker symbol NDOI.

“Trading on OTCQX is a clear signal that we are committed to living as a public company and providing shareholders with the convenience of trading as quickly as possible,” said Blaise ColemanChairman and Chief Executive Officer of Endo, Inc. “We remain focused on creating value for our shareholders while executing on our strategic priorities through the development and implementation of life-enhancing therapies. »

The OTCQX Marketplace provides a valuable and convenient trading experience for U.S. investors, brokers and institutions. It is OTC Markets Group’s premier marketplace, designed for established, investor-focused companies around the world. Eligibility to trade on this platform requires companies to meet strict financial and governance standards, adhere to U.S. securities laws and maintain transparent and up-to-date disclosure.

Endo continues to work with appropriate regulators, including the Securities and Exchange Commission, so that the Company’s shares may begin trading on the New York Stock Exchange (NYSE) later in 2024, subject to required approvals and other customary conditions.

U.S. investors can find current financial information and trading statistics, including real-time Level 2 quotes, for Endo at www.otcmarkets.com.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities. Any offer, solicitation of an offer to buy or sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About Endo
Endo is a diversified specialty pharmaceutical company boldly transforming knowledge into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best lives. Learn more at www.endo.com or connect with us on LinkedIn.

Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, statements by Mr. Coleman, any statements relating to the listing, listing or trading of the Company’s stock on the OTCQX, the NYSE or any other stock exchange, and any statement that refers to expected, estimated or anticipated future results or that does not relate solely to historical facts. Statements including words such as “believes,” “expects,” “anticipates,” “intends,” “estimates,” “plans,” “will,” “may,” “projects into future”, “intends”, “guidance”, “future”, “potential” or similar expressions are forward-looking statements. Because these statements reflect Endo’s current opinions, expectations and beliefs regarding future events, they involve risks and uncertainties, some of which Endo may not currently be able to anticipate. Although Endo believes that these forward-looking statements and other information are based on reasonable assumptions and expectations, readers should not place undue reliance on these or other forward-looking statements and information. Actual results may differ materially and adversely from current expectations depending on a number of factors. Endo undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as required by applicable securities laws.

The story continues

View original content to download multimedia: https://www.prnewswire.com/news-releases/endo-announces-commencement-of-otcqx-trading-302185078.html

SOURCE Endo, Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2024/28/c8585.html